Movement disorders

Primary Care - Clinics in Office Practice

Volumn 31, Issue 1, 2004, Pages 111-127

  Minagar, Alireza ^a   Kelley, Roger E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZATROPINE; BOTULINUM TOXIN A; BROMOCRIPTINE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; NIMODIPINE; PENICILLAMINE; PERGOLIDE; PRAMIPEXOLE; PRIMIDONE; PROPRANOLOL; ROPINIROLE; SELEGILINE; TETRATHIOMOLYBDIC ACID; THEOPHYLLINE; TOPIRAMATE; TRIENTINE; TRIHEXYPHENIDYL; UNINDEXED DRUG; ZINC ACETATE;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ESSENTIAL TREMOR; GASTROINTESTINAL TOXICITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NEUROPATHOLOGY; NEUROTOXICITY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; WILSON DISEASE;

EID: 2142701432     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(03)00119-2     Document Type: Review

References (15)

1. Payami H, Zareparsi S, James D, Nutt J. Familial aggregation of Parkinson's disease: a comparative study of early-onset and late onset disease. Arch Neurol 2002;59:848-50.
2. Dekker MCJ, Bonifati V, van Duijn CM. Parkinson's disease: piecing together a genetic jigsaw. Brain 2003;126:1-12.
3. Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000;54(11 Suppl 4):S2-6.
4. Glucher JR, Jonsson P, Kong A, et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 1997;17:84-7.
5. Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord 1997;12:859-64.
6. Louis ED, Shungu DC, Chan S, et al. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002;333:17-20.
7. Bain P, Brin M, Deuschl G, et al. Criteria for the diagnosis of essential tremor. Neurology 2000;54(Suppl 4):S7.
8. Huang CC, Chu NS, Yen TC, et al. Dopamine transporter binding in Wilson's disease. Can J Neurol Sci 2003;30:163-7.
9. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-8.
10. Hornsey H, Banerjee S. The prevalence of Tourette's syndrome in 13-14 year olds in mainstream schools. J Child Psychol Psychiatry 2001;42:1035-9.
11. Hoekstra PJ, Kallenberg CG, Korf J, Minderaa RB. Is Tourette's syndrome an autoimmune disease? Mol Psychiatry 2002;7:437-45.
12. Taylor JR, Morshed SA, Parveen S, et al. An animal model of Tourette's syndrome. Am J Psychiatry 2002;159:657-60.
13. Peterson BS, Thomas P, Kane MJ, et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003;60:415-24.
14. Jeffries KJ, Schooler C, Schoenbach C, et al. The functional neuroanatomy of Tourette's syndrome: an FDG PET study: III. functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology 2002;27:92-104.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington: American Psychiatric Association; 1994.